Breakdown of Paris Classification disease location in a cohort of all (n = 418) pediatric patients with Crohn’s disease diagnosed in Scotland between 2016 and 2020.
Disease location . | Total no. (%) . | + No upper GI disease . | + Upper GI disease . | L4a . | L4b . | L4a + b . |
---|---|---|---|---|---|---|
L1 | 62 (15) | 38 (61) | 24 (39) | 11 (18) | 7 (11) | 6 (10) |
L2 | 114 (27) | 77 (68) | 37 (32) | 30 (26) | 5 (4) | 2 (2) |
L3 | 197 (47) | 77 (39) | 120 (61) | 80 (41) | 20 (10) | 20 (10) |
Isolated L4 | 45 (11) |
Disease location . | Total no. (%) . | + No upper GI disease . | + Upper GI disease . | L4a . | L4b . | L4a + b . |
---|---|---|---|---|---|---|
L1 | 62 (15) | 38 (61) | 24 (39) | 11 (18) | 7 (11) | 6 (10) |
L2 | 114 (27) | 77 (68) | 37 (32) | 30 (26) | 5 (4) | 2 (2) |
L3 | 197 (47) | 77 (39) | 120 (61) | 80 (41) | 20 (10) | 20 (10) |
Isolated L4 | 45 (11) |
Abbreviation: GI, gastrointestinal.
Breakdown of Paris Classification disease location in a cohort of all (n = 418) pediatric patients with Crohn’s disease diagnosed in Scotland between 2016 and 2020.
Disease location . | Total no. (%) . | + No upper GI disease . | + Upper GI disease . | L4a . | L4b . | L4a + b . |
---|---|---|---|---|---|---|
L1 | 62 (15) | 38 (61) | 24 (39) | 11 (18) | 7 (11) | 6 (10) |
L2 | 114 (27) | 77 (68) | 37 (32) | 30 (26) | 5 (4) | 2 (2) |
L3 | 197 (47) | 77 (39) | 120 (61) | 80 (41) | 20 (10) | 20 (10) |
Isolated L4 | 45 (11) |
Disease location . | Total no. (%) . | + No upper GI disease . | + Upper GI disease . | L4a . | L4b . | L4a + b . |
---|---|---|---|---|---|---|
L1 | 62 (15) | 38 (61) | 24 (39) | 11 (18) | 7 (11) | 6 (10) |
L2 | 114 (27) | 77 (68) | 37 (32) | 30 (26) | 5 (4) | 2 (2) |
L3 | 197 (47) | 77 (39) | 120 (61) | 80 (41) | 20 (10) | 20 (10) |
Isolated L4 | 45 (11) |
Abbreviation: GI, gastrointestinal.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.